INVESTIGATIONS INTO HYPERLIPIDEMIA AND ITS POSSIBLE ...

182
97. Fojo SS, Stalenhoef AF, Marr K, et al. A deletion mutation in the apo C-II
gene (apo C-IINijmegen) of a patient with a deficiency of apolipoprotein C-II. J Biol
Chem 1988;263:17913-17916.
98. Fojo SS, Beisiegel U, Beil U, et al. Donor splice site mutation in the
apolipoprotein (apo) C-II gene (apo C-II Hamburg) of a patient with apo C-II deficiency.
J Clin Invest 1988;82:1489-1494.
99. Cox DW, Wills DE, Quan F, et al. A Deletion of one nucleotide results in
functional deficiency of apolipoprotein C-II (apo C-IIToronto). J Med Genet
1988;25:649-652.
100. Fojo SS, Degennes JL, Chapman J, et al. An initiation codon mutation in the
apo C-II gene (apo C-IIParis) of a patient with a deficiency of apolipoprotein C-II. J Biol
Chem 1989;264:20839-20842.
101. Fojo SS, Lohse P, Parrott C, et al. A nonsense mutation in the apolipoprotein
C-II gene in a patient with apolipoprotein C-II deficiency. J Clin Invest 1989;84:1215-
219.
102. Crecchio C, Capurso A, Pepe G. Identification of the mutation responsible
for a case of plasmatic apolipoprotein C-II deficiency (apo C-IIBari). Biochem Biophys
Res Commun 1990;168:1118-1127.
103. Hegele RA, Connelly PW, Maguire GF, et al. An apolipoprotein C-II
mutation, C-IILys19---Thr' identified in patients with hyperlipidemia. Dis Markers
1991;9:73-80.